| scholarly article | Q13442814 |
| P356 | DOI | 10.3233/JAD-2009-1134 |
| P698 | PubMed publication ID | 19625751 |
| P50 | author | Mauro Fà | Q43127464 |
| Ottavio Arancio | Q57733929 | ||
| P2093 | author name string | Hong Zhang | |
| David S Latchman | |||
| Yitshak I Francis | |||
| Agnieszka Staniszewski | |||
| Haider Ashraf | |||
| P433 | issue | 1 | |
| P921 | main subject | histone acetylation | Q14908264 |
| P304 | page(s) | 131-139 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. | |
| P478 | volume | 18 |
| Q35590452 | 'Relax and Repair' to restrain aging. |
| Q47578572 | Age-related epigenetic changes in hippocampal subregions of four animal models of Alzheimer's disease. |
| Q50993017 | Alzheimer's Disease and Histone Code Alterations. |
| Q92603838 | Alzheimer's disease: pathogenesis, diagnostics, and therapeutics |
| Q37228171 | An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome |
| Q26858963 | Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines |
| Q38676090 | Chromatin Changes Associated with Neuronal Maintenance and Their Pharmacological Application |
| Q34342179 | Chromatin remodeling, DNA damage repair and aging. |
| Q37361621 | Chromatin structure and transposable elements in organismal aging |
| Q47567142 | Co-location of HDAC2 and insulin signaling components in the adult mouse hippocampus |
| Q26774368 | Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis |
| Q41635420 | Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning. |
| Q101237411 | Disruption of Tip60 HAT mediated neural histone acetylation homeostasis is an early common event in neurodegenerative diseases |
| Q47866794 | Drebrin in Alzheimer's Disease. |
| Q48018264 | Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer's Disease. |
| Q42396584 | Environmental enrichment: aging and memory. |
| Q38199061 | Environmental factors in the development and progression of late-onset Alzheimer's disease |
| Q26770475 | Epigenetic Alterations in Alzheimer's Disease |
| Q28075559 | Epigenetic Changes in Neurodegenerative Diseases |
| Q64263723 | Epigenetic Modifications in Alzheimer's Neuropathology and Therapeutics |
| Q35753421 | Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging |
| Q34294750 | Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders |
| Q33858861 | Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. |
| Q83829640 | Epigenetic mechanisms in Alzheimer's disease |
| Q97570185 | Epigenetic mechanisms in Alzheimer's disease |
| Q38379396 | Epigenetic mechanisms in neurological and neurodegenerative diseases |
| Q34323841 | Epigenetic memory: the Lamarckian brain |
| Q47564897 | Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration |
| Q37870034 | Epigenetic regulation of gene expression in physiological and pathological brain processes |
| Q38207893 | Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction |
| Q35185570 | Epigenetic regulations of immediate early genes expression involved in memory formation by the amyloid precursor protein of Alzheimer disease |
| Q26772028 | Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response |
| Q39317395 | Epigenome Editing in the Brain |
| Q85263415 | Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics |
| Q36998001 | Genes and epigenetic processes as prospective pain targets |
| Q48322973 | Genetic sensitivity to the environment, across lifetime |
| Q48186683 | HDAC inhibition facilitates the switch between memory systems in young but not aged mice |
| Q41608936 | HDAC inhibitor-dependent transcriptome and memory reinstatement in cognitive decline models. |
| Q41628820 | HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease |
| Q38542044 | Histone Acetylation Modifiers in the Pathogenesis of Alzheimer's Disease |
| Q55008077 | Histone Deacetylase Inhibitor Alleviates the Neurodegenerative Phenotypes and Histone Dysregulation in Presenilins-Deficient Mice. |
| Q92927460 | Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery? |
| Q35134204 | Histone H4 lysine 16 hypoacetylation is associated with defective DNA repair and premature senescence in Zmpste24-deficient mice |
| Q34322979 | Histone acetylation: molecular mnemonics on the chromatin. |
| Q30440318 | Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition. |
| Q36140656 | Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain |
| Q38227853 | Histone-acetylation: a link between Alzheimer's disease and post-traumatic stress disorder? |
| Q35748624 | Increased EID1 nuclear translocation impairs synaptic plasticity and memory function associated with pathogenesis of Alzheimer's disease |
| Q30498541 | Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease |
| Q36939128 | Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant? |
| Q45305295 | Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity. |
| Q38085375 | Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. |
| Q28080843 | Molecular mechanisms of synaptic remodeling in alcoholism |
| Q51629038 | Multiplex detection of histone-modifying enzymes by total internal reflection fluorescence-based single-molecule detection. |
| Q35558250 | Neonatal isoflurane exposure induces neurocognitive impairment and abnormal hippocampal histone acetylation in mice |
| Q37238365 | Neuronal gene repression in Niemann-Pick type C models is mediated by the c-Abl/HDAC2 signaling pathway. |
| Q47319962 | Neuroprotective effects of artemisinin against isoflurane-induced cognitive impairments and neuronal cell death involve JNK/ERK1/2 signalling and improved hippocampal histone acetylation in neonatal rats |
| Q39196413 | Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model. |
| Q93080138 | Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau |
| Q29994749 | Paternal spatial training enhances offspring's cognitive performance and synaptic plasticity in wild-type but not improve memory deficit in Alzheimer's mice |
| Q58555658 | Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases |
| Q34970563 | Phenyl acyl acids attenuate the unfolded protein response in tunicamycin-treated neuroblastoma cells |
| Q43648215 | Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease |
| Q45954200 | Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model. |
| Q41661244 | Post-training, intrahippocampal HDAC inhibition differentially impacts neural circuits underlying spatial memory in adult and aged mice |
| Q38718079 | Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits |
| Q35485587 | Potential non-oncological applications of histone deacetylase inhibitors |
| Q38041123 | Potential of chromatin modifying compounds for the treatment of Alzheimer's disease |
| Q37872394 | Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity |
| Q30535298 | Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease |
| Q48150943 | Region- and age-specific patterns of histone acetylation related to spatial and cued learning in the water maze |
| Q36574016 | Regulation of Histone Acetylation by Autophagy in Parkinson Disease |
| Q34905146 | SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition |
| Q28834522 | Site-specific quantification of lysine acetylation in the N-terminal tail of histone H4 using a double-labelling, targeted UHPLC MS/MS approach |
| Q28564318 | Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus. |
| Q36097888 | Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, attenuates postoperative cognitive dysfunction in aging mice |
| Q93083881 | Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade |
| Q35064948 | Synaptic therapy in Alzheimer's disease: a CREB-centric approach |
| Q44787901 | Targeted proteomics for quantification of histone acetylation in Alzheimer's disease. |
| Q35224092 | Targeting HDACs: a promising therapy for Alzheimer's disease. |
| Q26771812 | Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases |
| Q38094663 | Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities |
| Q38036916 | Targeting synaptic dysfunction in Alzheimer's disease therapy. |
| Q57072881 | The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer's Disease |
| Q90704728 | The Hyperactivity-Impulsivity-Irritiability-Disinhibition-Aggression-Agitation Domain in Alzheimer's Disease: Current Management and Future Directions |
| Q36223734 | The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review |
| Q38793903 | The Vitamin A Derivative All-Trans Retinoic Acid Repairs Amyloid-β-Induced Double-Strand Breaks in Neural Cells and in the Murine Neocortex |
| Q34426210 | The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? |
| Q38527233 | The epigenetics of aging and neurodegeneration. |
| Q38234971 | The potential of epigenetic therapies in neurodegenerative diseases |
| Q37978548 | The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy |
| Q42149605 | Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease |
| Q34137377 | Tuning acetylation levels with HAT activators: Therapeutic strategy in neurodegenerative diseases |
| Q51779584 | Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease. |
| Q48710262 | Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action |
Search more.